Cargando…
Amyloid imaging in prodromal Alzheimer's disease
Patients with mild cognitive impairment are at an increased risk of progression to Alzheimer's disease. However, not all patients with mild cognitive impairment progress, and it is difficult to accurately identify those patients who are in the prodromal stage of Alzheimer's disease. In a r...
Autores principales: | Ossenkoppele, Rik, van Berckel, Bart NM, Prins, Niels D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218803/ https://www.ncbi.nlm.nih.gov/pubmed/21936965 http://dx.doi.org/10.1186/alzrt88 |
Ejemplares similares
-
Amyloid imaging in clinical trials
por: Ossenkoppele, Rik, et al.
Publicado: (2013) -
Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
por: Blennow, Kaj, et al.
Publicado: (2010) -
Examination of a non-invasive biomarker for the diagnosis of prodromal Alzheimer's disease and Alzheimer's disease Dementia
por: Dupree, Emmalyn J., et al.
Publicado: (2020) -
Do genetic factors contribute to sex-specific differences in resilience to
amyloid pathology?
por: Groot, Colin, et al.
Publicado: (2022) -
Cortical florbetapir-PET amyloid load in prodromal Alzheimer’s disease patients
por: Saint-Aubert, Laure, et al.
Publicado: (2013)